| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| TDP-43 | Human TDP-43 (263-414) Protein, His Tag | Human | E. coli | ![]() | SDS-PAGE | $120.00 25ug | ||
| TDP-43 | Human TDP-43 Protein, His Tag | Human | E. coli | ![]() | SDS-PAGE | $145.00 25ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Monepantel | PPL-1; NUZ-001 | Phase 3 Clinical | Pitney Pharmaceuticals Pty Ltd | Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Neoplasms | 상세 |
| nL-TARD-001 | nL-TARD-001 | Phase 2 Clinical | N-Lorem Foundation | Amyotrophic Lateral Sclerosis | 상세 |
| AMDX-2011P | AMDX2011P; AMDX-2011P | Phase 2 Clinical | Amydis Inc | Alzheimer Disease; Amyotrophic Lateral Sclerosis; Cerebral Amyloid Angiopathy; Glaucoma, Open-Angle; Parkinson Disease | 상세 |
| VTx-002 (VectorY) | VTx-002 | Phase 2 Clinical | VectorY BV | Amyotrophic Lateral Sclerosis | 상세 |
| CTx-1000 | CTx1000; CTx-1000 | Phase 1 Clinical | Celosia Therapeutics Pty Ltd | Amyotrophic Lateral Sclerosis | 상세 |
| AB-14 | AB-14 | Phase 1 Clinical | Autotac Bio Inc | Amyotrophic Lateral Sclerosis | 상세 |
